Contract facts
NONENo full NAICS 541720 intel page yet. Browse NAICS intelligence
STRENGTHENING LYME DISEASE SURVEILLANCE is a federal NONE award for Cdc Office Of Acquisition Services held by Westat, Inc. Estimated value $3M ($3M obligated). Current period of performance ends Sep 29, 2026. Last award drew 189 bidders. Place of performance: ROCKVILLE MD.
Recompete timing
PublicCurrent PoP ends Sep 29, 2026 (39 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordWestat, Inc — $855.5M obligated across 348 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75D30123C18329?
75D30123C18329 (Strengthening LYME disease surveillance) is a Cdc Office Of Acquisition Services award with a potential value of $3M, currently held by Westat, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75D30123C18329?
Cdc Office Of Acquisition Services awarded 75D30123C18329 to Westat, Inc (potential $3M).
Who is the incumbent on 75D30123C18329?
Westat, Inc is the incumbent with $855.5M across 348 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.
When does Westat, Inc’s 75D30123C18329 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.